DYN 424B5: Secondary offering
Filed with the SEC on · accession 0001193125-26-312576
DYN filed a 424B5 (prospectus (offering)) with the SEC on Jul 22, 2026. The final terms of an offering of shares or bonds. The stock moved -2.6% by the first close after the filing.
Summary of the filing
Dyne Therapeutics, Inc. is offering 18,300,000 shares of common stock at $20.50 per share, with an option for underwriters to purchase an additional 2,745,000 shares, expecting total gross proceeds of approximately $375.15 million.
Key details
How DYN stock reacted
Close before
$23.83
Jul 21, 2026
First close after
-2.60%
$23.21
5 trading days
+8.69%
$25.90
Since filing
-27.15%
$17.36
✦ Ask GOAX AI about this filing — what it means for DYN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for DYN?
Click hereFrequently asked questions
What did DYN file with the SEC on Jul 22, 2026?
DYN filed a 424B5 (Secondary offering). Dyne Therapeutics, Inc. is offering 18,300,000 shares of common stock at $20.50 per share, with an option for underwriters to purchase an additional 2,745,000 shares, expecting total gross proceeds of approximately $375.15 million.
What does a secondary offering mean for DYN stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did DYN stock react to this filing?
DYN closed at $23.83 before the filing and $23.21 on Jul 22, 2026 (-2.60%). Five trading days later: $25.90 (+8.69%).
Other DYN SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 29, 2026
- 8-K · SEC filingJul 29, 2026
- 10-Q · SEC filingJul 29, 2026
- 8-K · Secondary offeringJul 22, 2026
- 424B5 · Secondary offeringJul 21, 2026
- 8-K · Fda approvalJul 20, 2026
- 8-K · Board changeJun 22, 2026
- 8-K · Material agreementJun 17, 2026
Get alerts when DYN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days